Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Healthcare Tribune France.

Pharmaceutical Market Size Worth USD 3.03 Trillion by 2034
Ottawa, Oct. 07, 2025 (GLOBE NEWSWIRE) -- The global pharmaceutical market size is expected to be worth over USD 3.03 trillion by 2034, increasing from USD 1.77 trillion in 2025. It is expected to grow at a CAGR of 6.15% between 2025 and 2034. The...

Valneva Strengthens Financial Position by Refinancing Debt with Pharmakon Advisors and Provides Business Updates
New debt facility extends repayment from Q1 2026 to Q4 2030, lowers interest rate and provides access to additional capital for future business development Company adjusts 2025 financial guidance and provides key business updates Saint-Herblain...

Fermented Foods Market to Exceed USD 398.78 Billion by 2034, Fueled by Rising Health and Wellness Trends | Towards FnB
Ottawa, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The global fermented foods market size stood at USD 247.16 billion in 2024 and is predicted to increase from USD 259.27 billion in 2025 to reach nearly USD 398.78 billion by 2034, expanding at a CAGR of...

Advanced Healthcare Solutions Market Technology, Analytics and Top Companies
Ottawa, Oct. 06, 2025 (GLOBE NEWSWIRE) -- This advanced healthcare solutions market momentum is fueled by evolving patient expectations, rising demand for personalized care, and ongoing technological innovations reshaping the healthcare landscape....

Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programs
Exclusive collaboration and license agreement for the development and global commercialization of Arbor’s clinical-stage gene editing program, ABO-101 for primary hyperoxaluria type 1 (PH1) Multitarget research collaboration and option agreement...

Chiesi Group and Arbor Biotechnologies Announce a Global Strategic Partnership to Develop Novel Rare Disease Gene Editing Programmes
Exclusive collaboration and license agreement for the development and global commercialisation of Arbor’s clinical-stage gene editing programme, ABO-101 for primary hyperoxaluria type 1 (PH1) Multitarget research collaboration and option agreement...
EG 427 Receives U.S. FDA Fast Track Designation for EG110A DNA Medicine in Neurogenic Bladder Patients
Paris, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Builds on positive top-line data from first cohort demonstrating significant reduction in urinary incontinence episodes Paris, France, October 6, 2025 – EG 427, a biotechnology company leading the...
Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate
Former GSK and Sanofi executive, led Cervarix® development and advanced pioneering therapies for rare diseases, decade of experience as venture capitalist Strengthens Bioxodes leadership following encouraging Phase 2a interim data for lead...

Medical Device Outsourcing Market Insights: Contract Manufacturing, Regulatory Services & Growth | DataM Intelligence
The medical device outsourcing market was $127 Billion in 2023, projected to reach $340 Billion by 2031 at a CAGR of 13.1%. AUSTIN, TX, UNITED STATES, October 3, 2025 /EINPresswire.com/ -- According to DataM Intelligence, the medical device...
EG 427 Announces Compelling Initial Topline Clinical Results with EG110A DNA Medicine in Neurogenic Bladder Patients
Over 88% reduction in urinary incontinence episodes achieved in low dose cohort at 12 weeks Good tolerability with no systemic side effects First DNA medicine to selectively target, at the local level, a specific subtype of sensory neurons Fully...

France Pharmaceutical Packaging Market Worth USD 6.12 Bn by 2034
Ottawa, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The global France pharmaceutical packaging market was assessed at USD 3.23 billion in 2025, with projections indicating an increase to USD 6.12 billion by 2034, based on insights from Towards Packaging, a...

Healthcare Cyber Security Market Size Expected to Reach USD 112.6 Billion at 18.54% CAGR by 2034
Ottawa, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The global healthcare cyber security market size was valued at USD 20.56 billion in 2024 and is predicted to hit around USD 112.6 billion by 2034, rising at a 18.54% CAGR, a study published by Towards...

Sexual Wellness Market is slated to increase at a CAGR of 4.7% to reach a valuation of US$ 32.5 billion by 2033
By product, the sprays segment is projected to witness the highest CAGR of 5.3%, in revenue terms, during the forecast period. WILMINGTON, DE, UNITED STATES, October 3, 2025 /EINPresswire.com/ -- The global sexual wellness market size was valued...

DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Châtillon, France, October 6, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the...
![[Latest] Global Virtual Clinical Trials Market Size/Share Worth USD 15.8 Billion by 2034 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/1367fc91-c6ac-4844-bda8-61aa40bc3dff/global-virtual-clinical-trials-market-2025-2034-by-study-design-.png)
[Latest] Global Virtual Clinical Trials Market Size/Share Worth USD 15.8 Billion by 2034 at a 5.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Virtual Clinical Trials Market Size, Trends and Insights By Study Design (Interventional, Observational, Expanded Access), By...

Dassault Aviation: France Places New Falcon Albatros Order
France Places New Falcon Albatros Order Saint-Cloud, France, October 2, 2025 – On September 26, 2025, the French Defense Procurement and Technology Agency (DGA) placed an order with Dassault Aviation for five Falcon 2000 Albatros aircraft as part...

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...
![[Latest] Global Direct Reduced Iron Market Size/Share Worth USD 96.4 Billion by 2034 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/e6b0bd5c-f426-42d7-ab20-62abcd5df476/global-direct-reduced-iron-market-2025-2034-by-technology-.png)
[Latest] Global Direct Reduced Iron Market Size/Share Worth USD 96.4 Billion by 2034 at a 7.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Austin, TX, USA, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Direct Reduced Iron Market Size, Trends and Insights By Product Type (Hot Briquetted Iron, Cold Direct Reduced Iron), By...

Scality and Inria partner to develop intelligent, sovereign, and eco-responsible data storage, powered by AI, for France 2030
PARIS and SAN FRANCISCO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Scality, a global leader in cyber-resilient storage software for the AI era, and Inria, the French national research institute for digital science and technology, today announce their...

Igyxos Biotherapeutics Awarded EUR 5.7 Million from the French Government to Accelerate Development of its First-in-class Monoclonal Antibody for the Treatment of Infertility
TOURS, France, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Igyxos Biotherapeutics, a biotechnology company dedicated to developing innovative monoclonal antibodies for infertility treatment, today announced that it has secured a EUR 5.7 million grant under...